Avon To Integrate “Social Selling” In Direct-Sales Model With New Website
This article was originally published in The Rose Sheet
Executive Summary
Avon’s fiscal 2014 second quarter was “another tough one” for the firm, with revenue declining 13% on a reported basis and active representatives down 6%. To better engage and reward sales representatives and breathe new life its U.S. business, Avon plans to launch an overhauled e-commerce site in September, according to CEO Sheri McCoy, who said “social selling” is key to the company’s future.
You may also be interested in...
Avon Announces More Layoffs, Plans To Exit Ireland
As part of Avon Products Inc.’s previously announced $400 million Cost Saving Initiative, the firm has announced plans to exit Ireland and eliminate 400 positions globally, among other measures.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.